SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

77,434.67 524.99
( 0.68%)

Global Indices

Nasdaq

53,487.79 123.39
(0.23%)

Dow Jones

7,729.14 16.38
(0.21%)

Hang Seng

65,335.94 -2,124.79
(-3.15%)

Nikkei 225

10,747.45 19.41
(0.18%)

Forex

USD-INR

95.70 0.10
(0.10%)

EUR-INR

110.78 0.02
(0.01%)

GBP-INR

129.52 -0.04
(-0.03%)

JPY-INR

0.60 0.00
(-0.13%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Valiant Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543998

INE0JWS01017

58.8745685

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VALIANTLAB

37.86

499.68

EPS(TTM)

Face Value()

Div & Yield %

2.43

Back

Venus Remedies consolidated net profit rises 139.27% in the June 2026 quarter

Jul 21,2026

Net profit of Venus Remedies rose 139.27% to Rs 22.97 crore in the quarter ended June 2026 as against Rs 9.60 crore during the previous quarter ended June 2025. Sales rose 30.38% to Rs 178.86 crore in the quarter ended June 2026 as against Rs 137.18 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	178.86	137.18	30
OPM %	19.12	11.21	-
PBDT	36.81	18.78	96
PBT	30.04	12.60	138
NP	22.97	9.60	139

77,434.67 524.99 ( 0.68%)

53,487.79 123.39 (0.23%)

7,729.14 16.38 (0.21%)

65,335.94 -2,124.79 (-3.15%)

10,747.45 19.41 (0.18%)

95.70 0.10 (0.10%)

110.78 0.02 (0.01%)

129.52 -0.04 (-0.03%)

0.60 0.00 (-0.13%)